サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751249

放射線腫瘍学の市場規模、シェア、動向分析レポート：タイプ別、技術別、用途別、地域別、セグメント予測、2025年～2030年

Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 130 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
放射線腫瘍学の市場規模、シェア、動向分析レポート：タイプ別、技術別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月05日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

放射線腫瘍学市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の放射線腫瘍学市場規模は2030年に211億9,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 11.17％で成長すると予測されています。

同市場の成長は、世界のがん負担の増加、老年人口の増加、政府や民間団体が実施する支援償還プログラムに起因しています。さらに、放射線治療における技術革新と進歩の増加は、市場成長に有利な機会を提供しています。

世界では、がん患者の有病率が増加しており、これが放射線腫瘍学市場の成長を促進する主な要因となっています。例えば、Globocanによると、2020年には2,000万人以上ががんと診断され、1,000万人ががんで死亡しています。さらに、高齢化社会は免疫力の低下や併存疾患のためにがんのリスクが高いです。そのため、高齢者人口の増加が市場の成長をさらに促進しています。例えば、WHOの推計によると、2020年の世界の老人人口は約10億人で、2050年には21億人に達すると予想されています。

新しい放射線治療技術や集学的治療アプローチの開発のための広範な研究活動は、がんの生存率の向上と予後の良好化につながると期待されています。例えば、2022年12月、エレクタ・ユニティ社は、膵臓腫瘍に対するMR-Linacの使用を実証し、史上初の患者が新たな先進放射線治療モーションマネージメントで治療を受けた。

同様に2020年6月、イソレイはシンシナティ大学フィジシャンズカンパニーと頸部および頭部がん治療の調査契約を締結しました。両社は、外科的切除後のセシウム131とともにキイトルーダの有効性を評価します。このような医療用アイソトープをがん治療に使用することで、疾患の複雑性と患者のニーズを理解し、新たな標的特異的放射線治療システムの開発研究が促進される可能性があります。

さらに、放射線治療に対する支援的な償還および規制政策も、放射線腫瘍学市場の成長を促進すると予想されます。例えば、2021年7月、メディケア・メディケイド・サービスセンター（CMS）は、がんの診断と放射線治療サービスのための新しい放射線腫瘍学支払いモデル（RO-APM）を開発しました。これは、患者の治療の質を高め、メディケアの年間支出を削減するものです。

放射線腫瘍学市場レポートハイライト

  • 外照射療法（EBRT）市場は、線形加速器（リニアック）、小型先進放射線治療システムなどを含み、様々な種類のがんの治療への導入が増加しているため、2024年には市場全体で最大の収益シェアを占めました。
  • IMRTセグメントは、2024年に24.06％の最大収益シェアを占めました。これは、治療ニーズが満たされていない国々で、治療に対する大きな需要と技術的に先進的な強度変調放射線治療（IMRT）の利用可能性が高まったことに起因しています。
  • 前立腺がんに対するEBRTセグメントは、2024年に58.65％の最大の収益シェアを占め、予測期間中もその優位性を維持すると予測されています。
  • IBRT市場は、新興国市場でのがん罹患率の増加と製品普及率の上昇により、予測期間中に大きな成長が見込まれます。
  • 北米の放射線腫瘍学業界は、有利な政府のイニシアチブと技術的に高度な放射線治療機器の利用可能性により、2024年の収益シェアで47.16%と世界を支配しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 放射線腫瘍学市場の変数、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場動向と展望
  • 市場力学
    • 放射線治療の導入増加
    • 放射線治療における技術の進歩
    • がん罹患率の上昇
    • ヘルスケア費の増加
    • 放射性医薬品の応用拡大
  • 市場抑制要因分析
    • 熟練した放射線治療専門家の不足
    • 不十分な放射線インフラ
    • 放射線療法の副作用タイプ分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 放射線腫瘍学市場：タイプ別推定・動向分析

  • 放射線腫瘍学市場：タイプ別変動分析
  • タイプ別
  • 外部放射線療法
    • 線形加速器（ライナック）
    • コンパクトな先進放射線治療システム
    • 陽子線治療
  • 内部照射療法
    • 近接放射線療法
    • 全身放射線療法
    • その他

第5章 放射線腫瘍学市場：技術別推定・動向分析

  • 放射線腫瘍学市場：技術別変動分析
  • 技術別
  • 外部放射線療法
    • 画像誘導放射線治療（IGRT）
    • 強度変調放射線治療（IMRT）
    • 定位放射線治療技術
    • 陽子線治療
    • 3Dコンフォーマル放射線治療（3D CRT）
    • 体積変調アーク治療（VMAT）
  • 近接放射線療法
    • 低線量率密封小線源治療
    • 高線量率密封小線源治療

第6章 放射線腫瘍学市場：用途別推定・動向分析

  • 放射線腫瘍学市場：用途別変動分析
  • 用途別
  • 外部放射線療法
    • 前立腺がん
    • 乳がん
    • 肺がん
    • 頭頸部がん
    • 大腸がん
    • その他
  • 内部照射療法
    • 前立腺がん
    • 乳がん
    • 肺がん
    • 頭頸部がん
    • 大腸がん
    • その他

第7章 放射線腫瘍学市場：地域別推定・動向分析

  • 放射線腫瘍学の市場シェア：地域別、2024年および2030年
  • 地域別市場シェア分析、2024年および2030年
  • 地域別市場ダッシュボード
  • 地域別市場のスナップショット
  • 市場規模、予測動向分析、2018年～2030年
  • 北米
    • 北米の放射線腫瘍市場、2018年～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の放射線腫瘍市場、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋地域の放射線腫瘍市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの放射線腫瘍市場、2018年～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの放射線腫瘍市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 戦略マッピング
  • 企業市場シェア分析、2024年
  • 企業プロファイル
    • Varian Medical Systems, Inc.
    • Elekta AB
    • Accuray Incorporated
    • IBA Radiopharma Solutions
    • BD（Becton, Dickinson and Company）
    • Isoray Inc.
    • Mevion Medical Systems
    • Nordion, Inc.
    • NTP Radioisotopes SOC Ltd.
    • Curium
    • ViewRay Technologies, Inc.
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 3 Global Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Radiation Oncology Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Europe America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 UK Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 UK Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 UK Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 France Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 France Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Italy Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Spain Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Norway Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Norway Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Japan Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Japan Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Japan Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 China Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 India Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 India Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 India Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Australia Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Australia Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Australia Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Thailand Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Thailand Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 64 South Korea Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 South Korea Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Latin America Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Brazil Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Radiation Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Radiation Oncology Market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 audi Arabia Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Radiation Oncology Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Radiation Oncology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Radiation Oncology Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Radiation Oncology Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Radiation oncology market: Type movement analysis
  • Fig. 15 Radiation oncology market: Type outlook and key takeaways
  • Fig. 16 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 17 Linear Accelerators (Linac) market estimates and forecast, 2018 - 2030
  • Fig. 18 Compact advanced radiotherapy systems market estimates and forecast, 2018 - 2030
  • Fig. 19 Cyberknife market estimates and forecast, 2018 - 2030
  • Fig. 20 Gamma Knife market estimates and forecast, 2018 - 2030
  • Fig. 21 Tomotherapy market estimates and forecast, 2018 - 2030
  • Fig. 22 Proton Therapy market estimates and forecast, 2018 - 2030
  • Fig. 23 Cyclotron market estimates and forecast, 2018 - 2030
  • Fig. 24 Synchrotron market estimates and forecast, 2018 - 2030
  • Fig. 25 Internal Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 27 Seeds market estimates and forecast, 2018 - 2030
  • Fig. 28 Applicators and After loaders market estimates and forecast, 2018 - 2030
  • Fig. 29 Electronic Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 30 Systemic Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Radiation oncology market: Technology movement analysis
  • Fig. 33 Radiation oncology market: Technology outlook and key takeaways
  • Fig. 34 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 35 Image-Guided Radiotherapy (IGRT) market estimates and forecast, 2018 - 2030
  • Fig. 36 Intensity Modulated Radiotherapy (IMRT) market estimates and forecast, 2018 - 2030
  • Fig. 37 Stereotactic Technology market estimates and forecast, 2018 - 2030
  • Fig. 38 Proton Beam Therapy market estimates and forecast, 2018 - 2030
  • Fig. 39 3D Conformal Radiotherapy (3D CRT) market estimates and forecast, 2018 - 2030
  • Fig. 40 Volumetric Modulated Arc Therapy (VMAT) market estimates and forecast, 2018 - 2030
  • Fig. 41 Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 42 Low-Dose Rate Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 43 High-Dose Rate Brachytherapy market estimates and forecast, 2018 - 2030
  • Fig. 44 Radiation oncology market: Application movement analysis
  • Fig. 45 Radiation oncology market: Application outlook and key takeaways
  • Fig. 46 External Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 47 Prostate Cancer market estimates and forecast, 2018 - 2030
  • Fig. 48 Breast Cancer market estimates and forecast, 2018 - 2030
  • Fig. 49 Lung Cancer market estimates and forecast, 2018 - 2030
  • Fig. 50 Head and Neck Cancer market estimates and forecast, 2018 - 2030
  • Fig. 51 Colorectal Cancer market estimates and forecast, 2018 - 2030
  • Fig. 52 Others market estimates and forecast, 2018 - 2030
  • Fig. 53 Internal Beam Radiation Therapy market estimates and forecast, 2018 - 2030
  • Fig. 54 Prostate Cancer market estimates and forecast, 2018 - 2030
  • Fig. 55 Gynecological Cancer market estimates and forecast, 2018 - 2030
  • Fig. 56 Cervical Cancer market estimates and forecast, 2018 - 2030
  • Fig. 57 Breast Cancer market estimates and forecast, 2018 - 2030
  • Fig. 58 Penile Cancer market estimates and forecast, 2018 - 2030
  • Fig. 59 Others market estimates and forecast, 2018 - 2030
  • Fig. 60 Regional outlook, 2024 & 2030
  • Fig. 61 Global Radiation Oncology Market: Region movement analysis
  • Fig. 62 North America Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 63 U.S. Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 64 Canada Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 66 Europe Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 68 UK Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 69 France Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 70 Italy Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 72 Denmark Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 74 Norway Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 77 China Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 78 India Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 81 Thailand Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 85 Middle East and Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 87 Saudi Arabia Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 88 UAE Radiation Oncology Market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait Radiation Oncology Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-801-5

Radiation Oncology Market Growth & Trends:

The global radiation oncology market size is expected to reach USD 21.19 billion in 2030 and is projected to grow at a CAGR of 11.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the global rise in cancer burden, the growing geriatric population, and supportive reimbursement programs undertaken by the government and private organizations. Furthermore, the increasing technological innovation and advancement in radiotherapy offer lucrative opportunities for market growth.

The world is witnessing an increasing prevalence of cancer cases which is the key factor driving the radiation oncology market growth. For instance, according to Globocan, in 2020, more than 20.0 million people were diagnosed with cancer, and 10.0 million died of cancer. Moreover, the aging population is at high risk of cancer due to a weak immune system and comorbid conditions; thereby, the rising geriatric population further fuels market growth. For instance, in 2020, according to WHO estimates, the global geriatric population was approximately 1.0 billion and is expected to reach 2.1 billion by 2050.

Extensive research activities for the development of novel radiotherapy techniques and multidisciplinary therapeutic approaches are expected to lead to an increased survival rate and a more favorable prognosis of cancer. For instance, in December 2022, Elekta Unity demonstrated MR-Linac use for pancreatic tumors, where the first-ever patient was treated with new advanced radiotherapy motion management.

Similarly, in June 2020, Isoray signed a research agreement with the University of Cincinnati Physicians Company to study neck and head cancer treatment. The companies will evaluate the efficacy of Keytruda along with Cesium-131 post-surgical resection. Using such medical isotopes for cancer treatment may boost the research in developing a new target-specific radiation therapy system by understanding disease complexity & patients' need, thereby widening the opportunity in the market.

Furthermore, supportive reimbursement and regulatory policies for radiation therapy are also expected to drive the radiation oncology market growth. For instance, in July 2021, the Centers for Medicare and Medicaid Services (CMS) developed a new Radiation Oncology Payment Model (RO-APM) for the diagnosis of cancer and radiotherapy services. It enhances the quality of care of the patients and reduces the annual Medicare expenditure.

Radiation Oncology Market Report Highlights:

  • The external beam radiation therapy (EBRT) market, which includes linear accelerators (Linac), and compact advanced radiotherapy systems, dominated the overall market with the largest revenue share in 2024 due to increased adoption in the treatment of various types of cancers
  • The IMRT segment held the largest revenue share of 24.06% in 2024, attributed to the substantial demand for treatment and increased availability of technologically advanced intensity-modulated radiotherapy (IMRT) in countries with unmet treatment needs.
  • The EBRT segment for prostate cancer held the largest revenue share of 58.65% in 2024 and is anticipated to maintain its dominance over the forecast period
  • The market for IBRT is anticipated to witness significant growth over the forecast period due to the growing prevalence of cancer in developing countries and increased product penetration
  • North America radiation oncology industry dominated globally in terms of revenue share of 47.16% in 2024, owing to the favorable government initiatives and availability of technologically advanced radiotherapy equipment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Applicationoutlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Radiation Oncology Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising adoption of radiotherapy
    • 3.4.2. Technological advancements in radiotherapy
    • 3.4.3. Rising prevalence of cancer
    • 3.4.4. Increase in healthcare expenditure
    • 3.4.5. Increasing application of radiopharmaceuticalsg
  • 3.5. Market Restraint Analysis
    • 3.5.1. Lack Of Skilled Radiotherapy Professionals
    • 3.5.2. Inadequate Radiation Infrastructure
    • 3.5.3. Adverse Effects Of RadiotherapyType Analysis Tools
    • 3.5.4. Porter's Five Forces Analysis
    • 3.5.5. PESTEL Analysis

Chapter 4. Radiation Oncology Market: Type Estimates & Trend Analysis

  • 4.1. Radiation Oncology Market: Type Movement Analysis
  • 4.2. Radiation Oncology Market Estimates and Forecast, by Type
  • 4.3. External Beam Radiation Therapy
    • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Linear Accelerators (Linac)
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Compact advanced radiotherapy systems
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.2. Cyberknife
        • 4.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.3. Gamma Knife
        • 4.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.3.4. Tomotherapy
        • 4.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.4. Proton Therapy
      • 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.4.2. Cyclotron
        • 4.3.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.3.4.3. Synchrotron
        • 4.3.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4. Internal Beam Radiation Therapy
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Brachytherapy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Seeds
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Applicators and After loaders
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Electronic Brachytherapy
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Systemic Beam Radiation Therapy
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Radiation Oncology Market: Technology Estimates & Trend Analysis

  • 5.1. Radiation Oncology Market: Technology Movement Analysis
  • 5.2. Radiation Oncology Market Estimates and Forecast, by Technology
  • 5.3. External Beam Radiation Therapy
    • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Image-Guided Radiotherapy (IGRT)
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Intensity Modulated Radiotherapy (IMRT)
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Stereotactic Technology
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Proton Beam Therapy
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.6. 3D Conformal Radiotherapy (3D CRT)
    • 5.3.7. Volumetric Modulated Arc Therapy (VMAT)
      • 5.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Brachytherapy
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Low-Dose Rate Brachytherapy
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. High-Dose Rate Brachytherapy
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Radiation Oncology Market: Application Estimates & Trend Analysis

  • 6.1. Radiation Oncology Market: Application Movement Analysis
  • 6.2. Radiation Oncology Market Estimates and Forecast, by End Use
  • 6.3. External Beam Radiation Therapy
    • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Prostate Cancer
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Breast Cancer
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Lung Cancer
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.5. Head and Neck Cancer
      • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.6. Colorectal Cancer
      • 6.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.7. Others
      • 6.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Internal Beam Radiation Therapy
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Prostate Cancer
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Breast Cancer
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Lung Cancer
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Head and Neck Cancer
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Colorectal Cancer
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Radiation Oncology Market: Regional Estimates & Trend Analysis

  • 7.1. Radiation Oncology Market Share By Region, 2024 & 2030
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Global Regional Market Snapshot
  • 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. North America Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. U.S. Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.3. Canada
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Canada Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Mexico Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.7. Europe
    • 7.7.1. Europe Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.2. UK
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. UK Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.3. Germany
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Germany Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.4. France
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. France Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.5. Italy
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Italy Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.6. Spain
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Spain Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.7. Denmark
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Denmark Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.8. Sweden
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Sweden Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.7.9. Norway
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Norway Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.8. Asia Pacific
    • 7.8.1. Asia Pacific Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.2. Japan
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Japan Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.3. China
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. China Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.4. India
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. India Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.5. Australia
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Australia Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.6. Thailand
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Thailand Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.8.7. South Korea
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. South Korea Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.9. Latin America
    • 7.9.1. Latin America Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.9.2. Brazil
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Brazil Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.9.3. Argentina
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Argentina Radiation Oncology Market, 2018 - 2030 (USD Million)
  • 7.10. MEA
    • 7.10.1. MEA Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.2. South Africa
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. South Africa Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.3. Saudi Arabia
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Saudi Arabia Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.4. UAE
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. UAE Radiation Oncology Market, 2018 - 2030 (USD Million)
    • 7.10.5. Kuwait
      • 7.10.5.1. Key Country Dynamics
      • 7.10.5.2. Competitive Scenario
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Kuwait Radiation Oncology Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Strategy Mapping
  • 8.4. Company Market Share Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Varian Medical Systems, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Elekta AB
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Accuray Incorporated
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. IBA Radiopharma Solutions
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. BD (Becton, Dickinson and Company)
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Isoray Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Mevion Medical Systems
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Nordion, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. NTP Radioisotopes SOC Ltd.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Curium
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. ViewRay Technologies, Inc.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives